AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMLODIPINE+ATENOLOL

9 registrations across 2 African markets— 3 active

Markets with AMLODIPINE+ATENOLOL

Recent registrations

Brand / ProductMarketHolderStatusExpires
NOVATEN AM 5MG/50MG COMPRIME BOITE DE 28🇨🇮Côte d'IvoireAJANTA PHARMAexpiredMar 2025
AMLOCLASS_AT 5MG/50MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireIMPACT HEALTH CARE PVT. LTDexpiredJan 2025
AMLOAS-AT 5MG/50MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireLABORATOIRES ASMOH LABORATORIES LIMITEDexpiredDec 2023
AMLONEX AT 5MG/50MG COMPRIME BOITE DE 100🇨🇮Côte d'IvoireNIYA HEALTHCARE PVT. LTDexpiredJan 2023
AMLORAV-AT 5MG/50MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireZYDUS LIFESCIENCES LIMITEDexpiredJul 2022
AMLOSTAR PLUS 5MG/50MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireSTRIDES PHARMA SCIENCE LIMITEDexpiredAug 2019
AMLOVAS-AT
comprimé / 5 mg / 50 mg
🇸🇳SenegalASMOHactive
AMLOAS-AT
comprimé / 50 mg / 5 mg
🇸🇳SenegalASMOHactive
AMLOAS-AT
comprimé / 50 mg / 5 mg
🇸🇳SenegalASMOHactive

AMLODIPINE+ATENOLOL in Africa — Regulatory Overview

AMLODIPINE+ATENOLOL is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 3 (33%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.